ACE inhibitor (BF = 0.5455): potential usefulness in regulating blood pressure and cardiovascular health; DPP-IV inhibitor (BF = 0.4545): possible role in metabolic regulation and diabetes management. This evidence concerns the gene ACE and diabetes mellitus.